T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment

Autor: Hanna K. Isotalus, Christopher R. Madan, Volkan Nurdal, Alfie Wearn, Risto A. Kauppinen, Elizabeth Coulthard, Esther Saunders-Jennings, Sean-James Fallon, Michael J. Knight
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
T2 relaxometry
Aging
Neuropsychological Tests
0302 clinical medicine
Cognition
magnetic resonance imaging
Beacon - Precision Imaging
Cognitive decline
Aged
80 and over

05 social sciences
Neurodegeneration
Middle Aged
Alzheimer's disease
Early diagnosis
Magnetic Resonance Imaging
Hippocampal subfields
Temporal Lobe
medial temporal lobe
T2 heterogeneity
Neurology
Medial temporal lobe
Female
RC321-571
early diagnosis
Cognitive Neuroscience
Neurosciences. Biological psychiatry. Neuropsychiatry
050105 experimental psychology
Article
Temporal lobe
03 medical and health sciences
Atrophy
Alzheimer Disease
medicine
Humans
0501 psychology and cognitive sciences
Cognitive Dysfunction
Aged
business.industry
Mechanism (biology)
Dentate gyrus
medicine.disease
Entorhinal cortex
hippocampal subfields
Ageing
ageing
business
Neuroscience
030217 neurology & neurosurgery
Zdroj: Wearn, A R, Nurdal, V, Saunders-Jennings, E, Knight, M J, Madan, C R, Fallon, S-J, Isotalus, H K, Kauppinen, R A & Coulthard, E J 2021, ' T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment ', NeuroImage, vol. 238, 118214 . https://doi.org/10.1016/j.neuroimage.2021.118214
Neuroimage
NeuroImage, Vol 238, Iss, Pp 118214-(2021)
ISSN: 1053-8119
Popis: A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructural changes relevant to early stages of pathology. Recent evidence suggests heterogeneity of T2 may be a more informative MRI measure of early pathology than absolute T2. Here we test whether T2 markers of brain integrity precede the volume changes we know are present in established AD and whether such changes are most marked in medial temporal lobe (MTL) subfields known to be most affected early in AD. We show that T2 heterogeneity was greater in people with mild cognitive impairment (MCI; n = 49) compared to healthy older controls (n = 99) in all MTL subfields, but this increase was greatest in MTL cortices, and smallest in dentate gyrus. This reflects the spatio-temporal progression of neurodegeneration in AD. T2 heterogeneity in CA1-3 and entorhinal cortex and volume of entorhinal cortex showed some ability to predict cognitive decline, where absolute T2 could not, however further studies are required to verify this result. Increases in T2 heterogeneity in MTL cortices may reflect localised pathological change and may present as one of the earliest detectible brain changes prior to atrophy. Finally, we describe a mechanism by which memory, as measured by accuracy and reaction time on a paired associate learning task, deteriorates with age. Age-related memory deficits were explained in part by lower subfield volumes, which in turn were directly associated with greater T2 heterogeneity. We propose that tissue with high T2 heterogeneity represents extant tissue at risk of permanent damage but with the potential for therapeutic rescue. This has implications for early detection of neurodegenerative diseases and the study of brain-behaviour relationships.
Databáze: OpenAIRE